Jennifer Litton, MD | Authors

Articles

Addressing the Role of PARP Inhibitors in Different Breast Cancer Settings

April 10, 2018

Jennifer Litton, MD, associate professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses her opinion on the use of PARP inhibitors in the field of breast cancer.

Exploring Biosimilars in the Field of Breast Cancer

April 09, 2018

Jennifer Litton, MD, associate professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the role of biosimilars in the treatment of breast cancer.